Found 73 matching trials
Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Drugs in Patients With Elevated Cholesterol Levels (0653A-058)
PHASE3A 10-week study to compare the reduction in cholesterol following treatment...
Location
Multiple Locations
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
PHASE1This is an exploratory study in a small, well controlled group of healthy s...
Location
Jasper Clinical Research & Development, Inc.
Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe
NAAmong patients with stable coronary artery disease (CAD), it is not clear i...
Location
Heart Institute (InCor) HOSPITAL DAS CLINICAS DA FACULDADE DE MEDICINA DA UNIVERSIDADE DE SAO PAULO (HCFMUSP)
Eze/Simva Switch Study in Diabetics (0653A-807)
PHASE3A study to assess the effectiveness and tolerability of MK0653A and MK0653A...
Location
Multiple Locations
Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
PHASE4The purpose of this study is to determine whether, in patients with chronic...
Location
Istituto di Patologia Medica - Azienda Ospedaliero Universitaria
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
PHASE4To determine whether the combination of ezetimibe and simvastatin improves ...
Location
VA Maryland Health Care System
Study of Heart and Renal Protection
PHASE4The chief aim of SHARP was to determine whether lowering blood LDL choleste...
Location
Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford
EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
PHASE4In patients with coronary artery disease and a LDL-C level between 2.5 mmol...
Location
Multiple Locations
Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes
PHASE4It is of interest how ezetimibe alone or in combination with statin may inf...
Location
Institut für Stoffwechselforschung
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
PHASE3The primary aim is to assess the effects of raising HDL cholesterol (the go...
Location
Clinical Trial Service Unit, University of Oxford